17-43853974-C-G
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The ENST00000317310.5(CD300LG):āc.649C>Gā(p.Pro217Ala) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000167 in 1,614,204 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. P217L) has been classified as Uncertain significance.
Frequency
Consequence
ENST00000317310.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
CD300LG | NM_145273.4 | c.649C>G | p.Pro217Ala | missense_variant | 4/7 | ENST00000317310.5 | NP_660316.2 | |
LOC107985077 | XR_001752896.2 | n.180+437G>C | intron_variant, non_coding_transcript_variant |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
CD300LG | ENST00000317310.5 | c.649C>G | p.Pro217Ala | missense_variant | 4/7 | 1 | NM_145273.4 | ENSP00000321005 | P2 |
Frequencies
GnomAD3 genomes AF: 0.000158 AC: 24AN: 152208Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000916 AC: 23AN: 251226Hom.: 0 AF XY: 0.0000883 AC XY: 12AN XY: 135880
GnomAD4 exome AF: 0.000168 AC: 245AN: 1461878Hom.: 0 Cov.: 31 AF XY: 0.000172 AC XY: 125AN XY: 727242
GnomAD4 genome AF: 0.000164 AC: 25AN: 152326Hom.: 0 Cov.: 32 AF XY: 0.000161 AC XY: 12AN XY: 74480
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Oct 27, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at